COVID-19 in decompensated cirrhosis
Elderly patients with diabetes, hypertension and obesity are at risk of severe course of the novel coronavirus infection COVID-19. Patients with chronic liver disease are also at high risk of severe course and death due to SARS-CoV-2. Case report. Patient D., 65 years old, since 2010, was observed f...
Saved in:
| Main Authors: | O. V. Tashchyan, M. G. Mnatsakanyan, A. P. Pogromov, I. V. Kuprina, Yu. F. Shumskaya |
|---|---|
| Format: | Article |
| Language: | Russian |
| Published: |
Federal Research Center of Transplantology and Artificial Organs named after V.I.Shumakov
2021-01-01
|
| Series: | Вестник трансплантологии и искусственных органов |
| Subjects: | |
| Online Access: | https://journal.transpl.ru/vtio/article/view/1284 |
| Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
Similar Items
-
Post COVID Condition and Long‐Term COVID‐19 Impact on Hepatic Decompensation and Survival in Cirrhosis: A Propensity Matched Observational Study
by: Prerna Sharma, et al.
Published: (2025-03-01) -
Recurrent Massive Hydrothorax in a Patient with Decompensated Liver Cirrhosis
by: K. S. Zemlyanukhina, et al.
Published: (2024-10-01) -
Immunogenicity of COVID-19 vaccines in patients with cirrhosis: A meta-analysis
by: Lichen Ouyang, et al.
Published: (2024-12-01) -
Correction of renal dysfunction in patients with the decompensated course of cirrhosis
by: A. S. Tugushev, et al.
Published: (2014-06-01) -
Evaluating Disparities in COVID‐19 Clinical Outcomes Among Patients With Cirrhosis in North America and Europe—An International Registry Study
by: Umar Hayat, et al.
Published: (2024-12-01)